Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
105.5 INR | -3.65% | -11.83% | +1.88% |
Kurzporträt
Mitarbeiterzahl: 1 496
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceuticals - Manufactured
99,6
%
| 10 375 | 99,9 % | 12 029 | 99,6 % | +15.94% |
Pharmaceuticals - Traded
0,4
%
| 11 | 0,1 % | 44 | 0,4 % | +297.99% |
Services
0,0
%
| 1 | 0,0 % | 0 | 0,0 % | -67.69% |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
International
77,6
%
| 7 960 | 76,6 % | 9 374 | 77,6 % | +17.76% |
India
22,4
%
| 2 427 | 23,4 % | 2 699 | 22,4 % | +11.22% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 04.01.95 |
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Gagan Aggarwal
DFI | Director of Finance/CFO | - | 29.09.18 |
Vijay Singla
COO | Chief Operating Officer | 49 | - |
Pardeep Verma
CMP | Compliance Officer | - | - |
Lalit K. Wadhwa
COO | Chief Operating Officer | - | 16.06.11 |
Varun Chhabra
SAM | Sales & Marketing | - | - |
Ashok Prasad
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | - | |
Vikas Narendra
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 04.01.95 |
Director/Board Member | 68 | 31.08.09 | |
Rishav Mehta
BRD | Director/Board Member | 33 | 23.03.10 |
Director/Board Member | 74 | 31.12.14 | |
Neerja Chathley
BRD | Director/Board Member | 69 | 10.05.19 |
Sahil Munjal
BRD | Director/Board Member | 43 | 13.02.20 |
Director/Board Member | 67 | 23.06.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 59 086 918 | 19 416 499 ( 32,86 %) | 0 | 32,86 % |
Unternehmenskontakt
Ind-Swift Laboratories Ltd.
SCO 850, Shivalik Enclave NAC
160101, Manimajra
+91 17 2506 1850
http://www.indswiftlabs.comSektor
Umsatz nach Geschäftsbereich
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+1.88% | 77.52 Mio. | |
+18.67% | 43.74 Mrd. | |
+21.99% | 22.26 Mrd. | |
+16.41% | 14.9 Mrd. | |
+9.03% | 13.39 Mrd. | |
+40.48% | 12.12 Mrd. | |
-9.64% | 6.92 Mrd. | |
-0.05% | 6.79 Mrd. | |
-8.87% | 5.73 Mrd. | |
+13.13% | 5.47 Mrd. |
- Börse
- Aktien
- A40CMM Aktie
- Unternehmen Ind-Swift Laboratories Limited